Title : Screening and Identification of Key Biomarkers in Acquired Lapatinib-Resistant Breast Cancer.

Pub. Date : 2020

PMID : 33013420






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Lapatinib, targeting the human epidermal growth factor receptor family members HER1 and HER2, has been approved by the US Food and Drug Administration for use in metastatic HER2-positive breast cancer. Lapatinib epidermal growth factor receptor Homo sapiens
2 Lapatinib, targeting the human epidermal growth factor receptor family members HER1 and HER2, has been approved by the US Food and Drug Administration for use in metastatic HER2-positive breast cancer. Lapatinib epidermal growth factor receptor Homo sapiens